The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector

Abstract

There is a need to strengthen post-marketing surveillance systems to protect patients from being treated with sub-standard and counterfeit antimalarial drugs in Kenya.